ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody drug targets immune system to fight advanced cancers
Disease control OngoingThis early-phase study tests a new drug called ADG206 in people with advanced solid tumors that have not responded to standard treatments. ADG206 is designed to boost the immune system's ability to fight cancer by activating a protein called CD137 on immune cells. The main goals …
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Adagene Inc • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug candidate targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-stage study tests an experimental drug called FDA018-ADC in about 78 adults with advanced solid tumors (like breast, lung, or bladder cancer) that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if i…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC